Position in RLAY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,510,531
+$2,352,048 QoQ
Shares Held
241,076
+11.1% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. RLAY ranks #53 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,510,531 | 241,076 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,158,483 | 216,933 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,825,168 | 215,741 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,135,830 | 217,592 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $767,611 | 221,853 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $456,207 | 174,125 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $706,349 | 171,444 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,118,016 | 157,912 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,068,595 | 163,895 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,298,012 | 156,387 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,667,409 | 151,445 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,288,218 | 153,177 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,863,979 | 148,406 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,232,673 | 135,560 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,925,228 | 128,864 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,652,164 | 118,559 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,849,819 | 110,437 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,257,859 | 75,438 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,149,730 | 70,001 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,946,693 | 61,741 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,153,870 | 58,865 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,738,248 | 50,282 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,678,192 | 40,380 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,559,177 | 36,609 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||